ESR1 and breast carcinoma: AIs block the conversion of androstenedione into estrogen and are found to be more effective than tamoxifen in treating post menopausal women with ER+ breast cancers.90–92 Though, lot of cytotoxic drugs is available, but still challenges in treatment remains.